A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Clinical trial NCT00343187 · TERMINATED

Trial details

NCT number: NCT00343187
Sponsor: Allergan
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Rash Non-small-Cell Lung Cancer

Start date: 2006-06-01
Primary completion: 2007-07-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.